PMID- 12172694 OWN - NLM STAT- MEDLINE DCOM- 20030107 LR - 20131121 IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 162 IP - 4 DP - 2002 Aug TI - Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. PG - 406-14 AB - RATIONALE: Swim stress decreases extracellular serotonin (5-HT) levels in the rat lateral septum, and adaptation to this effect occurs with repeated swimming. Corticotropin-releasing factor (CRF) administered into the dorsal raphe nucleus (DRN) also decreases 5-HT release in the lateral septum, suggesting that CRF may mediate the effects of swim stress. OBJECTIVES: The hypothesis that endogenous CRF mediates the reduction of 5-HT levels in the lateral septum evoked by swim stress and is involved in the adaptation that occurs with repeated swim stress was tested. METHODS: Extracellular 5-HT levels in rat lateral septum were quantified by means of in vivo microdialysis. Extracellular single unit activity was recorded from the DRN. RESULTS: Intracerebroventricular (i.c.v.) administration of a CRF receptor antagonist prevented the ability of swim stress to decrease 5-HT release in the lateral septum. Prior exposure to swim stress reduced the ability of both CRF (i.c.v.) and a subsequent swim stress to decrease lateral septum 5-HT release (cross adaptation). Additionally, the effects of CRF, administered into the DRN, on DR neuronal discharge were attenuated in rats with a history of swim stress. Finally, administration of a CRF receptor antagonist (i.c.v.) between two swim stress sessions restored the neurochemical response to swim stress (i.e., 5-HT levels were reduced during the second exposure to swim). CONCLUSIONS: Endogenous CRF modulates 5-HT transmission during acute environmental stress and is also integral to adaptation of the 5-HT response produced by repeated stress. Modulation of the 5-HT system by CRF during acute stress may underlie certain coping behaviors, while stress-induced adaptation of this effect may be involved in psychiatric manifestations of repeated stress. FAU - Price, Michelle L AU - Price ML AD - David Mahoney Institute Neurological Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Kirby, Lynn G AU - Kirby LG FAU - Valentino, Rita J AU - Valentino RJ FAU - Lucki, Irwin AU - Lucki I LA - eng GR - MH 00842/MH/NIMH NIH HHS/United States GR - MH 36262/MH/NIMH NIH HHS/United States GR - MH 58250/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20020629 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (phenylalanyl corticotropin-releasing factor (12-41)) RN - 333DO1RDJY (Serotonin) RN - 9015-71-8 (Corticotropin-Releasing Hormone) SB - IM MH - Analysis of Variance MH - Animals MH - Corticotropin-Releasing Hormone/*analogs & derivatives/*pharmacology/physiology MH - Electrophysiology MH - Male MH - Microdialysis MH - Raphe Nuclei/drug effects/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Septum of Brain/drug effects/*metabolism MH - Serotonin/*metabolism MH - Stress, Physiological/physiopathology MH - Swimming MH - Time Factors EDAT- 2002/08/13 10:00 MHDA- 2003/01/08 04:00 CRDT- 2002/08/13 10:00 PHST- 2001/12/10 00:00 [received] PHST- 2002/03/27 00:00 [accepted] PHST- 2002/08/13 10:00 [pubmed] PHST- 2003/01/08 04:00 [medline] PHST- 2002/08/13 10:00 [entrez] AID - 10.1007/s00213-002-1114-2 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2002 Aug;162(4):406-14. doi: 10.1007/s00213-002-1114-2. Epub 2002 Jun 29.